Peritoneal cytology and preoperative serum CA 125 level are important prognostic indicators of overall survival in advanced endometrial cancer

被引:0
作者
Santala, M [1 ]
Talvensaari-Mattila, A [1 ]
Kauppila, A [1 ]
机构
[1] Oulu Univ, Dept Obstet & Gynecol, FIN-90029 Oys, Finland
关键词
CA; 125; endometrial cancer; flow cytometry; peritoneal cytology; prognosis;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The current study aimed to evaluate flow cytometry findings, peritoneal cytology and preoperative CA 125 level as prognostic factors of endometrial carcinoma. Patients and Methods: A retrospective study of 44 patients with FIGO stage II-IV endometrial carcinoma who underwent abdominal hysterectomy, bilateral salpingo-oophorectomy and, all except three, pelvic lymph node dissection. At operation, a peritoneal washing sample was taken for cytological examination. Flow cytometry was performed on fresh primary tumor samples. Blood samples were obtained within 2 weeks before surgery. The median follow-up time was 54 months. Results: In univariate analysis, DNA ploidy, S-phase fraction, serum CA 125 level and peritoneal cytological findings correlated significantly with survival. In multivariate analysis, peritoneal cytology (benign versus malignant), grade (1+2 versus 3) and preoperative serum CA 125 concentration (less than or equal to 25 U/ml versus > 25 U/ml) remained significant independent predictors of overall survival. DNA ploidy and S-phase fraction had a strong correlation with peritoneal cytology. Malignant cytological findings were more frequent in cases with DNA aneuploidy and S-phase fraction higher than 8%. Conclusion: In addition to histological grade, peritoneal cytology and preoperative serum CA 125 level were also important independent prognostic indicators of outcome.
引用
收藏
页码:3097 / 3103
页数:7
相关论文
共 23 条
[1]  
Chew S. H., 1999, Annals Academy of Medicine Singapore, V28, P266
[2]   PROGNOSTIC VALUE OF DNA-PLOIDY AND S-PHASE FRACTION IN ENDOMETRIAL CANCER STAGE-I AND STAGE-II - A PROSPECTIVE 5-YEAR SURVIVAL STUDY [J].
FRIBERG, LG ;
NOREN, H ;
DELLE, U .
GYNECOLOGIC ONCOLOGY, 1994, 53 (01) :64-69
[3]   Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer? [J].
Hsieh, CH ;
ChangChien, CC ;
Lin, H ;
Huang, EY ;
Huang, CC ;
Lan, KC ;
Chang, SY .
GYNECOLOGIC ONCOLOGY, 2002, 86 (01) :28-33
[4]   EVALUATION OF DNA-PLOIDY IN ENDOMETRIAL CANCER [J].
IKEDA, M ;
WATANABE, Y ;
NANJOH, T ;
NODA, K .
GYNECOLOGIC ONCOLOGY, 1993, 50 (01) :25-29
[5]   PERITONEAL CYTOLOGY IN PATIENTS WITH ENDOMETRIAL CARCINOMA [J].
IMACHI, M ;
TSUKAMOTO, N ;
MATSUYAMA, T ;
NAKANO, H .
GYNECOLOGIC ONCOLOGY, 1988, 30 (01) :76-86
[6]   EXPERIENCE WITH PELVIC WASHINGS IN STAGE-I AND STAGE-II ENDOMETRIAL CARCINOMA [J].
KENNEDY, AW ;
PETERSON, GL ;
BECKER, SN ;
NUNEZ, C ;
WEBSTER, KD .
GYNECOLOGIC ONCOLOGY, 1987, 28 (01) :50-60
[7]  
KUMAR D, 1994, MODERN PATHOL, V7, P354
[8]   Hysteroscopic dissemination of endometrial carcinoma using carbon dioxide and normal saline: A retrospective study [J].
Lo, KWK ;
Cheung, TH ;
Yim, SF ;
Chung, TKH .
GYNECOLOGIC ONCOLOGY, 2002, 84 (03) :394-398
[9]   Assessment of prognostic factors in stage IIIA endometrial cancer [J].
Mariani, A ;
Webb, MJ ;
Keeney, GL ;
Aletti, G ;
Podratz, KC .
GYNECOLOGIC ONCOLOGY, 2002, 86 (01) :38-44
[10]  
Mariani L, 2000, ANTICANCER RES, V20, P3569